Savara Inc
NASDAQ:SVRA

Watchlist Manager
Savara Inc Logo
Savara Inc
NASDAQ:SVRA
Watchlist
Price: 2.78 USD 2.96%
Market Cap: 477.1m USD

P/OCF
Price to OCF

-5.8
Current
-7.6
Median
20.4
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-5.8
=
Market Cap
474.9m USD
/
Operating Cash Flow
-81.4m USD
Market Cap P/OCF
US
Savara Inc
NASDAQ:SVRA
474.9m USD -5.8
FR
Pharnext SCA
OTC:PNEXF
6T USD -230 913.9
US
Abbvie Inc
NYSE:ABBV
356.5B USD 19
US
Amgen Inc
NASDAQ:AMGN
164.1B USD 14.3
US
Gilead Sciences Inc
NASDAQ:GILD
138.3B USD 12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
128B USD -262.1
US
Epizyme Inc
F:EPE
94.1B EUR -487.2
AU
CSL Ltd
ASX:CSL
122.4B AUD 26.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
69.3B USD 15.8
US
Seagen Inc
F:SGT
39.3B EUR -78.6
NL
argenx SE
XBRU:ARGX
32.7B EUR -137.5
 
US
Savara Inc
NASDAQ:SVRA
Average P/OCF: 17.6
Negative Multiple: -5.8
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -230 913.9
US
Abbvie Inc
NYSE:ABBV
19
US
Amgen Inc
NASDAQ:AMGN
14.3
US
Gilead Sciences Inc
NASDAQ:GILD
12.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -262.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -487.2
AU
CSL Ltd
ASX:CSL
26.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -78.6
NL
argenx SE
XBRU:ARGX
Negative Multiple: -137.5

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A